Navigation Links
Surveyed EU5 Pulmonologists Expect that Relvar, the First Once-Daily LABA/ICS FDC, Will Experience Healthy Uptake in Asthma
Date:7/24/2014

BURLINGTON, Mass., July 24, 2014 /PRNewswire/ -- Decision Resources Group finds that, for the treatment of asthma, pulmonologists in the EU5 countries (France, Germany, Italy, Spain and the United Kingdom) hold a generally positive view of the first once-daily long-acting beta2 agonist/inhaled corticosteroid (LABA/ICS) fixed-dose combination (FDC), Relvar (GlaxoSmithKline/Theravance). EU5 pulmonologists expect robust uptake of Relvar as a first-line LABA/ICS FDC in the treatment of asthma with one-quarter to half of surveyed pulmonologists considering the drug as a first-line maintenance therapy for treatment-naive persistent asthma patients. However, interviewed payers across EU5 countries caution that in order for Relvar to secure premium pricing, superior efficacy data over Seretide (GlaxoSmithKline) would be required. Thus, despite its lower dosing frequency, the existing noninferiority data for Relvar will most likely drive an equivalent price to that of currently available twice-daily LABA/ICS FDCs.

Other key findings from the European Physician and Payer Forum report entitled Asthma in the EU5: What Are the Expectations for Optimal Positioning of New and Emerging Inhaled and Biological Therapies in Market Access Systems?:

  • Market-access hurdles for emerging biologics: Interviewed payers and surveyed pulmonologists across the EU5 view the ability to identify likely responders as a benefit for the emerging anti-IL-5 therapies -- Cinquil (Cephalon/Teva), Bosatria (GlaxoSmithKline) and benralizumab (MedImmune/AstraZeneca). However, payers anticipate the cost of such diagnostic testing could be a hurdle for reimbursement and uptake.
  • Impact
    '/>"/>

SOURCE Decision Resources Group
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. According to Surveyed Oncologists in the EU5, Zytiga Has Heavily Penetrated Second-Line Treatment of Metastatic Castrate-Resistant Prostate Cancer (mCRPC) and is Displacing Jevtana to Later-Line mCRPC
2. Surveyed U.S. and European Neurologists Agree that a Therapys Effect on Physical Disability is the Most Important Attribute Influencing Prescribing Decisions in Secondary-Progressive Multiple Sclerosis
3. Despite the Recent Availability of Xtandi, Zytiga Continues to Dominate the Second-Line Metastatic Castrate-Resistant Prostate Cancer Setting, According to Surveyed U.S. Oncologists and Urologists
4. Surveyed U.S. Physicians Indicate That Xarelto and Apixaban Will Benefit From the Lack of Use of a Fast-Acting Injectable Anticoagulant in the Treatment and Secondary Prophylaxis of Deep Vein Thrombosis/Pulmonary Embolism
5. Surveyed U.S. Neurologists Would Prescribe Biogen Idecs Tecfidera to 20 Percent of Their Patients with Relapsing-Remitting Multiple Sclerosis (RR-MS)
6. Surveyed U.S. Pulmonologists Expect to Treat Nearly 50 Percent of Their Severe, Refractory Asthma Patients With a Biologic or Biosimilar Version of Xolair By the End of 2018
7. For Treating Clostridium difficile Infections, Surveyed Infectious Disease Specialists Agree That Effect on Recurrence Rate is One of the Drug Attributes that Most Influences Their Prescribing Decisions
8. The Majority of Surveyed Gastroenterologists in the EU5 Identify Remicade as Their Most Preferred Biologic for the Treatment of Ulcerative Colitis
9. For Chronic Obstructive Pulmonary Disease, Surveyed Pulmonologists Indicate That Improved Effect on Quality of Life is One of the Greatest Unmet Needs
10. For Second- and Subsequent-Line Metastatic Castrate-Resistant Prostate Cancer, Surveyed Oncologists Indicate that Improved Symptom Control and Quality of Life is one of the Greatest Unmet Needs
11. Rising Drug Resistance is Driving Early-Line Use of Powerful Antibiotics Such as Carbapenems for Gram-Negative Infections, According to Surveyed EU5 Physicians
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... TWINSBURG, Ohio , Aug. 31, 2015 /PRNewswire/ ... and applications, has acquired MACTek Corporation, a leading ... part of Pepperl+Fuchs, strategy to further extend its ... the WirelessHART market.    "We are ... to our existing portfolio," said Jim Bolin ...
(Date:8/31/2015)... , Aug. 31, 2015  Daktari Diagnostics today announced a ... United States and Canada , ... The deal, worth up to $8.5 million over the next ... clinical validation and regulatory approval of Daktari,s HCV test. ... point-of-care instrument that can detect low levels of virus directly ...
(Date:8/31/2015)... , Aug. 31, 2015  On August 5, 2015, ... Oregon denied motions to dismiss securities ... GALE ) and certain of its directors. The class ... "pump and dump" scheme to artificially inflate Galena,s stock ... the stock price was inflated, sold massive amounts of ...
Breaking Medicine Technology:Daktari Enters Collaboration Agreement with Merck to Develop Test for Hepatitis C Virus 2Daktari Enters Collaboration Agreement with Merck to Develop Test for Hepatitis C Virus 3Galena Biopharma, Inc. Stock Alert: Schubert Firm Investigates Potential Breaches of Fiduciary Duty 2
... Mich., Oct. 19 Stryker Corporation (NYSE: SYK ... 2010 as follows: Third Quarter Highlights ... currency basis (6.9% as reported) to $1,768 million Orthopaedic ... as reported) MedSurg Equipment sales increased 16.3% on ...
... SCOTTSDALE, Ariz., Oct. 19 Matrixx Initiatives, Inc. (Nasdaq: ... financial results for the fiscal 2011 second quarter and six ... market closes on Monday, October 25, 2010. An earnings conference ... 26, 2010 at 11:00 AM ET. To access ...
Cached Medicine Technology:Stryker Reports 7% Sales Growth, 14% Adjusted Net Earnings Growth for Quarter Ended September 30, 2010 2Stryker Reports 7% Sales Growth, 14% Adjusted Net Earnings Growth for Quarter Ended September 30, 2010 3Stryker Reports 7% Sales Growth, 14% Adjusted Net Earnings Growth for Quarter Ended September 30, 2010 4Stryker Reports 7% Sales Growth, 14% Adjusted Net Earnings Growth for Quarter Ended September 30, 2010 5Stryker Reports 7% Sales Growth, 14% Adjusted Net Earnings Growth for Quarter Ended September 30, 2010 6Stryker Reports 7% Sales Growth, 14% Adjusted Net Earnings Growth for Quarter Ended September 30, 2010 7Stryker Reports 7% Sales Growth, 14% Adjusted Net Earnings Growth for Quarter Ended September 30, 2010 8Matrixx Initiatives, Inc. Sets Time for Discussion of Fiscal 2011 Second Quarter Financial Results 2
(Date:9/1/2015)... ... September 01, 2015 , ... Virginia entrepreneur ... is still strongly maintaining her firm’s success in the hair care and distribution ... upcoming city-to-city tour, Ellis will be providing “Look and learn” live demonstrations, as ...
(Date:9/1/2015)... (PRWEB) , ... September 01, 2015 , ... ... real-time monitoring and analysis of pet vital signs and activity, today announced its ... one of the most popular and widely-adopted veterinary hospital Practice Management Software packages ...
(Date:9/1/2015)... ... September 01, 2015 , ... Zecurion, a leading developer of ... groundbreaking new version of endpoint DLP developed specifically for Mac OS. , In June ... than 100 IT and information security professionals had participated. The beta test done by ...
(Date:9/1/2015)... ... 2015 , ... SC&H Group, a leading audit, tax, and consulting firm, received ... the Best” firm in the U.S., as well as being ranked a Top 100 ... the U.S., selected exclusively on performance in specific areas of financial and operational management. ...
(Date:9/1/2015)... ... September 01, 2015 , ... CanAm Enterprises ... have received permanent green cards (I-829 petition approval) from the USCIS through an ... the final step of the EB-5 visa process for immigrant investors to become ...
Breaking Medicine News(10 mins):Health News:Beauty Entrepreneur creates hair extension smart machine and mobile app inspired by UBER technology 2Health News:Petpace-Cornerstone Integration Lowers Overhead, Raises Data Visibility for Veterinary Practices 2Health News:Zecurion Announces Endpoint Security for Mac 2Health News:SC&H Group Receives Multiple Honors from INSIDE Public Accounting 2Health News:CanAm Enterprises Reaches Another Milestone with More Than 1,500 I-829 Petition Approvals 2
... by excruciating headache and nausea, are much worse for ... Researchers say migraine sufferers who lack private health ... about twice as likely to get inadequate treatment for ... Medicaid also get substandard care. Because migraine is ...
... The molecular machinery that switches on a gene known to ... been identified by an international team led by scientists at ... paper was published Sunday in Nature Cell Biology ,s ... for development of drugs to thwart expression of the RhoA ...
... ... the industry are faced with the daunting task to either establish or rethink their B2C ... more urgent by new government regulations, fees and taxes, and ever-present competitive factors that will ... ...
... levels linked to age-related macular degeneration, studies show ... studies provide more evidence of a genetic link between ... and the regulation of so-called "good" cholesterol in the ... nor are they near finding better treatments for the ...
... doesn,t affect men, who process carbohydrates more slowly, expert says ... in carbohydrates that are quickly transformed into sugar in the ... new Italian study finds. , The same effect, however, is ... 12 in the Archives of Internal Medicine . , ...
... ... Host ,T-shirt Design Contest in Celebration of National Nurses Week., , ... (PRWEB) April 12, 2010 -- Medical ... clothing website , has announced the ‘Give It a Shot: Nurses Week T-shirt Challenge’ ...
Cached Medicine News:Health News:Uninsured get poor care for migraine: Harvard study 2Health News:Scientists find key to gene that promotes cancer metastasis 2Health News:ConnextionsHealth Poised to Help Organizations Leverage Revenue-Driving Opportunities Related to Health Reform 2Health News:ConnextionsHealth Poised to Help Organizations Leverage Revenue-Driving Opportunities Related to Health Reform 3Health News:Gene Variant May Raise Risk of Common Eye Disease 2Health News:Simple Carbs Pose Heart Risk for Women 2Health News:Simple Carbs Pose Heart Risk for Women 3Health News:Medical Solutions Announces Nurses Week Contest 2Health News:Medical Solutions Announces Nurses Week Contest 3
... feature a 2 adjustable belt buckle. You adjust ... the Apron off your shoulders. And now theres ... the female anatomy. ,For additional back support try ... reduce pressure on the vertebrae and help "lift ...
... modular and flexible system that can record up to ... the comfort of their home. The recorder weighs less ... pouch. The alkaline batteries are in a separate compartment ... standard flash memory card. EEG data recording time can ...
... on over 20 years of experience ... for the Life Sciences, the Freedom ... and possibilities for expansion according to ... easy-to-use software, Freedom EVOware, each system ...
... PROVISION Surgical Helmet System from DePuy offers ... This system helps meet OSHA recommendations regarding ... while creating a new standard for comfort. ... to offer unequaled comfort, featuring a lightweight, ...
Medicine Products: